Results

Total Results: 1,355 records

Showing results for "clinical practice guideline".
Users also searched for: clinical practice guidelines

1321. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
      March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…

1322. Ch 2-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
      January 01, 2011 - 21 Abstract The choice of study design often has profound consequences for the causal interpretation of study results. The objective of this chapter is to provide an overview of various study design options for nonexperimental comparative effectiveness research (CER), with their relative advantages and limitations,…

1323. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
      January 01, 2020 - CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries Comparative Effective Review Disposition of Comments Report Research Review Title: Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Ou…

1324. Antiplatelet-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
      September 01, 2013 - 1 Comparative Effectiveness Review Number 125 Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment Executive Summary Background Burden of Disease and Clinical Setting Approximately 82 million Americans currently suffer from some form of cardiovascular disease.1 In the United …

1325. Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection in Children (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
      January 01, 2017 - Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection in Children 1 Comparative Effectiveness Review Number 183 Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection in Children Executive Summary Introduction Tonsillectomy or adenotonsillectomy…

1326. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
      December 31, 2013 - AHRQ Comparative Effectiveness Review Surveillance Program CER #27: Oral Diabetes Medications for Adults with Type 2 Diabetes: An Update Original release date: March 2011 Surveillance Report: December 2013 Key Findings: • For Key Question 1, conclusions on comparative effectiveness of oral diabetes agent…

1327. Autism Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
      October 01, 2012 - CER # 26: Therapies for Children with Autism Spectrum Disorders (ASDs) Original release date: April, 2011 Surveillance Report, 1st Assessment: January, 2012 Surveillance Report, 2nd Assessment: October, 2012 Key Findings, 1st Assessment: • For Key Question 1, conclusions regarding intensive early interven…

1328. Trauma-Child-Interventions Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_executive.pdf
      February 01, 2013 - 1 Comparative Effectiveness Review Number 107 Child and Adolescent Exposure to Trauma: Comparative Effectiveness of Interventions Addressing Trauma Other Than Maltreatment or Family Violence Executive Summary Background Approximately two-thirds of children and adolescents will experience at least one traum…

1329. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
      December 23, 2015 - Untitled Source: www.effectivehealthcare.ahrq.gov Published online: December 23, 2015 Evidence-based Practice Center Systematic Review Protocol Project Title: Suicide Prevention I. Background and Objectives for the Systematic Review Despite advances in the diagnosis and treatment of major mental disord…

1330. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
      January 01, 2020 - Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States Evidence Report/Technology Assessment Disposition of Comments Report Research Review Title: Safety of Vaccines Used for Routine Immunization in the United States Draft review avai…

1331. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
      January 01, 2015 - Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports AHRQ Healthcare Horizon Scanning System Report of a Pilot Project: Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports Prepared for: Agency for Healthcare Research and Quality U.S. Depart…

1332. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
      January 01, 2022 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in surveillance reports for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number …

1333. Binge-Eating Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating_executive.pdf
      December 01, 2015 - 1 Comparative Effectiveness Review Number 160 Management and Outcomes of Binge-Eating Disorder Executive Summary Background Definition of Binge-Eating Disorder and Loss-of-Control Eating Binge-eating disorder (BED) is characterized by recurrent episodes of binge eating—i.e., eating episodes that occur in …

1334. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
      March 01, 2018 - Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy Methods Research Report Supplemental Project To Assess the Transparency of Reporting Requirements for Studies E…

1335. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
      January 01, 2012 - AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 08: Functional Limitations and Disability Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov …

1336. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
      January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

1337. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
      January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

1338. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
      August 01, 2016 - Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review Context and Purpose of Review The value of omega 3 fatty acids (n-3 FA) intake to improve cardiovascular outcomes and risk factors remains controversial. This review updates prior Evidence Reports on this topic. The n-3 FA under review in…

1339. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
      August 24, 2012 - Comparative Effectiveness Review Disposition of Comments Report Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1235 Published Online: August 24, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research …

1340. Glaucoma-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
      April 01, 2012 - 1 Comparative Effectiveness Review Number 60 Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness both in the United States and worldwide. It is estimated to affect 60.5 million people worldwide.1 Glaucoma is defined as…